Skip to main content
OpenTrials

Clinical trial condition

Neoplastic Syndromes, Hereditary

Explore clinical trials studying Neoplastic Syndromes, Hereditary. Study availability and eligibility vary by location and protocol.

869 public trials 154 recruiting studies
Refine in advanced search Browse all conditions

Neoplastic Syndromes, Hereditary trial results

Completed

Study to Assess the Safety of Alpelisib Plus Fulvestrant, in Men and Post-menopausal Women With HR-positive, HER2-negative, Advanced Breast Cancer (aBC) With PIK3CA Mutation, Whose Disease Progressed on or After Endocrine Treatment

NCT05631795

Conditions
Advanced Breast Cancer, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine Gland Neoplasms, +8 more
Locations
  • Novartis Investigative Site Guwahati, Assam, India
  • Novartis Investigative Site Surat, Gujarat, India
  • Novartis Investigative Site Thalassery, Kerala, India
  • Novartis Investigative Site Trivandrum, Kerala, India
View Trial Details
Completed

Pharmacogenetic Study of Antimitotic Therapies Involved in Hepatic VOD in Children With Nephroblastoma or ALL

NCT04168788

Conditions
Acute Lymphoblastic Leukemia, Cardiovascular Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +30 more
Locations
  • Univesity Hostipal of Amiens Amiens, France
  • University Hospital of Bordeaux Bordeaux, France
  • University of Brest Brest, France
  • Centre Oscar Lambret Lille, France
View Trial Details
Completed

Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke

NCT03872401

Conditions
Cardiovascular Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Coronary Disease, +13 more
Locations
  • North Alabama Research Center LLC Athens, Alabama, United States
  • Cardiovascular Associates Birmingham, Alabama, United States
  • Heart Center Research LLC Huntsville, Alabama, United States
  • Mobile Heart Specialists PC Mobile, Alabama, United States
View all 852 locations
View Trial Details
Completed

A Rollover Study of Alectinib in Patients With Anaplastic Lymphoma Kinase (ALK)-Positive or Rearranged During Transfection (RET)-Positive Cancer

NCT03194893

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +15 more
Locations
  • Chao Family Comprehensive Cancer Center Orange, California, United States
  • Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
  • Centre Francois Baclesse Caen, France
  • Centre Georges François Leclerc Dijon, France
View all 29 locations
View Trial Details

Related conditions